Looking At Amgen's Recent Unusual Options Activity

Comments
Loading...

Someone with a lot of money to spend has taken a bearish stance on Amgen AMGN.

And retail traders should know.

We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with AMGN, it often means somebody knows something is about to happen.

So how do we know what this whale just did?

Today, Benzinga's options scanner spotted 12 uncommon options trades for Amgen.

This isn't normal.

The overall sentiment of these big-money traders is split between 25% bullish and 75%, bearish.

Out of all of the special options we uncovered, 6 are puts, for a total amount of $551,305, and 6 are calls, for a total amount of $194,384.

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $270.0 to $325.0 for Amgen over the last 3 months.

Volume & Open Interest Development

In terms of liquidity and interest, the mean open interest for Amgen options trades today is 395.88 with a total volume of 1,468.00.

In the following chart, we are able to follow the development of volume and open interest of call and put options for Amgen's big money trades within a strike price range of $270.0 to $325.0 over the last 30 days.

Amgen Option Volume And Open Interest Over Last 30 Days

Options Call Chart

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
AMGN PUT SWEEP NEUTRAL 01/17/25 $280.00 $205.2K 164 69
AMGN PUT SWEEP BEARISH 04/19/24 $290.00 $163.9K 213 62
AMGN PUT TRADE BULLISH 02/16/24 $280.00 $49.8K 71 30
AMGN PUT SWEEP BULLISH 11/17/23 $325.00 $45.2K 0 9
AMGN PUT TRADE BULLISH 02/16/24 $275.00 $45.1K 68 30

Where Is Amgen Standing Right Now?

  • With a volume of 2,364,726, the price of AMGN is down -2.06% at $273.06.
  • RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
  • Next earnings are expected to be released in 8 days.

What The Experts Say On Amgen:

  • Leerink Partners upgraded its action to Outperform with a price target of $318
  • Oppenheimer has decided to maintain their Outperform rating on Amgen, which currently sits at a price target of $300.
  • Argus Research has decided to maintain their Buy rating on Amgen, which currently sits at a price target of $310.
  • B of A Securities downgraded its action to Neutral with a price target of $290
  • JP Morgan downgraded its action to Neutral with a price target of $270

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Amgen, Benzinga Pro gives you real-time options trades alerts.

Overview Rating:
Speculative
50%
Technicals Analysis
66
0100
Financials Analysis
40
0100
Overview
Market News and Data brought to you by Benzinga APIs
Date of Trade
▲▼
ticker
▲▼
Put/Call
▲▼
Strike Price
▲▼
DTE
▲▼
Sentiment
▲▼

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!